Advanced search    

Search: authors:"Matthias G. Vossen"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection

SummaryBackgroundNovel drugs for Clostridium difficile (C. difficile) infections have been proven to reduce recurrent infections. Because of their high financial costs, identification of patients at high risk for recurrence is essential to provide optimal treatment. The ATLAS score’s ability to predict 90-day recurrence, disease complications and 1‑year all-cause mortality was...

In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin—layer (PRF)—a laboratory evaluation of a modern, autologous wound treatment

effect of amikacin and PRF could be shown. Author Contributions Conceptualization: Matthias G. Vossen. Data curation: Daniela Knafl, Matthias G. Vossen. Formal analysis: Daniela Knafl, Matthias G ... . Vossen. Funding acquisition: Matthias G. Vossen. Investigation: Daniela Knafl, Matthias G. Vossen. Methodology: Matthias G. Vossen. Resources: Matthias G. Vossen. Supervision: Florian Thalhammer

The SYBR Green I Malaria Drug Sensitivity Assay: Performance in Low Parasitemia Samples

November 27, 2009. Authors addresses: Matthias G. Vossen and Harald Noedl, Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna

Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh: An Open-Label Randomized, Controlled Clinical Trial

Background. In recent studies, the combination of azithromycin and artesunate has proven to be a promising alternative for the treatment of uncomplicated falciparum malaria. Methods. We conducted a randomized, controlled clinical trial assessing the efficacy of azithromycin-artesunate combination therapy. The study was conducted involving 228 patients aged 8–65 years. Patients...